Graft-versus-host disease -: From the bench to the bedside?

被引：10
作者：
Socié, G [1 ]
机构：
[1] Univ Paris 07, Hop St Louis, Serv Hematol Greffe de Moelle, Paris, France
[2] INSERM, U728, Paris, France
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 13期
关键词：
D O I：
10.1056/NEJMe058175
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1396 / 1397
页数：2
相关论文
共 13 条
[1]  
ANTIN JH, 1992, BLOOD, V80, P2964
[2]   Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management [J].
Couriel, D ;
Caldera, H ;
Champlin, R ;
Komanduri, K .
CANCER, 2004, 101 (09) :1936-1946
[3]   Acute and chronic Graft-versus-Host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation [J].
Couriel, DR ;
Saliba, RM ;
Giralt, S ;
Khouri, I ;
Andersson, B ;
de Lima, M ;
Hosing, C ;
Anderlini, P ;
Donato, M ;
Cleary, K ;
Gajewski, J ;
Neumann, J ;
Ippoliti, C ;
Rondon, G ;
Cohen, A ;
Champlin, R .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) :178-185
[4]   CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation [J].
Edinger, M ;
Hoffmann, P ;
Ermann, J ;
Drago, K ;
Fathman, CG ;
Strober, S ;
Negrin, RS .
NATURE MEDICINE, 2003, 9 (09) :1144-1150
[5]  
FERRARA JLM, 1991, NEW ENGL J MED, V324, P667
[6]   Donor-type CD4+CD25+ regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation [J].
Hoffmann, P ;
Ermann, J ;
Edinger, M ;
Fathman, CG ;
Strober, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :389-399
[7]   The future of allogeneic hematopoietic stem cell transplantation: minimizing pain, maximizing gain [J].
Little, MT ;
Storb, R .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (12) :1679-1681
[8]   Protective conditioning for acute graft-versus-host disease [J].
Lowsky, R ;
Takahashi, T ;
Liu, YP ;
Dejbakhsh-Jones, S ;
Grumet, FC ;
Shizuru, JA ;
Laport, GG ;
Stockerl-Goldstein, KE ;
Johnston, LJ ;
Hoppe, RT ;
Bloch, DA ;
Blume, KG ;
Negrin, RS ;
Strober, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1321-1331
[9]   Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation [J].
Mielcarek, M ;
Martin, PJ ;
Leisenring, W ;
Flowers, MED ;
Maloney, DG ;
Sandmaier, BM ;
Maris, MB ;
Storb, R .
BLOOD, 2003, 102 (02) :756-762
[10]   Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: End of the beginning and future challenges [J].
Satwani, P ;
Harrison, L ;
Morris, E ;
Del Toro, G ;
Cairo, MS .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (06) :403-422
12